This week we highlight vaccine mandate considerations, the lack of diversity on the boards of life sciences companies, a promising new class of drugs and more. … READ MORE >
Life sciences
5 things to know in life sciences: Week of March 29
From biopharma merger scrutiny to AI-powered biology research, we highlight what’s happening in the life sciences industry this week. … READ MORE >
CHART OF THE DAY: FTC challenges biopharma merger as antitrust scrutiny grows
Less than two weeks after the Federal Trade Commission announced it would be taking a more stringent look at mergers in the biopharmaceutical industry, the proposed Illumina and Grail merger became only the second vertical merger in 40 years to be legally challenged by the agency. … READ MORE >
5 things to know in life sciences: Week of March 22
This week we highlight AstraZeneca-Oxford COVID-19 vaccine challenges, FDA trends, drug-pricing reform hearings and more. … READ MORE >
5 things to know in life sciences: Week of March 15
This week we highlight possible heightened scrutiny related to pharma mergers, top drugs losing their exclusivity this year, artificial intelligence-powered hearing aids and more. … READ MORE >
An evolution of the economy: Living, and adapting, with COVID-19
What should middle market businesses consider in terms of a COVID-19 endemic future? Evaluating existing business models, updating policies and making investments in technology and digital infrastructure are just a few components. … READ MORE >
Understanding the rapid spread of COVID-19 variants
The emergence of COVID-19 variants is why the efficient and equitable distribution of vaccines across all nations is critical. … READ MORE >
5 things to know in life sciences: Week of March 8
This week we examine COVID-19 variants, heightened scrutiny on accelerated approval phase 4 confirmatory trials, gaps in the understanding of racial and ethnic representation in vaccine trials, tiny cancer-fighting robots and more. … READ MORE >
5 things to know in life sciences: Week of March 1
In this week’s roundup we look at new data coming out of the U.K. and Israel on their COVID-19 vaccination programs’ results. We also highlight improvements in public perception of the pharmaceutical industry, a new executive order on supply chains and more. … READ MORE >
5 things to know in life sciences: Week of Feb. 22
In this week’s roundup we look at the latest news on Johnson & Johnson’s vaccine, a federal effort to expand genomic sequencing to track new COVID-19 variants, a major merger in the industry, and more.
… READ MORE >